| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 59.1488 | 64 |
| GSM780708 | Untreated after 4 days (C2_1) | 66.466 | 68 |
| GSM780709 | Untreated after 4 days (C3_1) | 54.9276 | 59 |
| GSM780719 | Untreated after 4 days (C1_2) | 64.7588 | 67 |
| GSM780720 | Untreated after 4 days (C2_2) | 53.7135 | 57 |
| GSM780721 | Untreated after 4 days (C3_2) | 57.7259 | 63 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 63.381 | 66 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 63.0642 | 66 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 67.3064 | 68 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 55.9441 | 61 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 62.9142 | 66 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 61.1868 | 65 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 71.1466 | 69 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 69.2446 | 69 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 63.795 | 67 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 65.6111 | 67 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 55.4361 | 60 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 58.0378 | 63 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 58.5402 | 63 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 65.2721 | 67 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 65.9784 | 68 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 72.5229 | 70 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 59.6313 | 64 |